Skip to main content
. 2023 Jun 30;28:206. doi: 10.1186/s40001-023-01176-6

Table 2.

Main causes of death for patients with localized kidney cancer

Causes of death Total Clear cell RCC Non-clear cell RCC
Observed, n Expected, n SMR (95% CI) Observed, n Expected, n SMR (95% CI) Observed, n Expected, n SMR (95% CI)
All causes of death 30,390 19,151.73 1.59# (1.57–1.6) 12,549 8,512.19 1.47# (1.45–1.5) 17,841 10,639.55 1.68# (1.65–1.7)
All malignant cancers 12,022 4,575.66 2.63# (2.58–2.67) 5,118 2,095.27 2.44# (2.38–2.51) 6,904 2,480.39 2.78# (2.72–2.85)
Urinary system 7,500 260.56 28.78# (28.14–29.44) 3,267 117.66 27.77# (26.82–28.74) 4,233 142.9 29.62# (28.74–30.53)
 Kidney and renal pelvis 7,161 111.5 64.22# (62.74–65.73) 3,220 51.54 62.48# (60.34–64.67) 3,941 59.96 65.73# (63.69–67.81)
 Urinary bladder 277 141.91 1.95# (1.73–2.2) 44 62.87 0.70# (0.51–0.94) 233 79.03 2.95# (2.58–3.35)
Respiratory system 1,315 1,318.67 1 (0.94–1.05) 538 606.11 0.89# (0.81–0.97) 777 712.56 1.09# (1.02–1.17)
 Lung and bronchus 1,283 1,277.13 1 (0.95–1.06) 529 587.53 0.90# (0.83–0.98) 754 689.6 1.09# (1.02–1.17)
Digestive system 1,276 1,176.37 1.08# (1.03–1.15) 566 540.52 1.05 (0.96–1.14) 710 635.85 1.12# (1.04–1.2)
 Pancreas 393 308.78 1.27# (1.15–1.41) 174 143.53 1.21# (1.04–1.41) 219 165.25 1.33# (1.16–1.51)
 Colon and rectum 315 403.3 0.78# (0.7–0.87) 140 181.26 0.77# (0.65–0.91) 175 222.04 0.79# (0.68–0.91)
 Liver and intrahepatic bile duct 275 183.41 1.50# (1.33–1.69) 126 86.78 1.45# (1.21–1.73) 149 96.63 1.54# (1.3–1.81)
Male genital system 183 324.19 0.56# (0.49–0.65) 72 132.98 0.54# (0.42–0.68) 111 191.22 0.58# (0.48–0.7)
 Prostate 178 319.62 0.56#(0.48–0.65) 71 130.87 0.54# (0.42–0.68) 107 188.74 0.57# (0.46–0.69)
Brain and other nervous system 159 100.52 1.58#(1.35–1.85) 68 49.1 1.38# (1.08–1.76) 91 51.42 1.77# (1.42–2.17)
Leukemia 190 182.42 1.04 (0.9–1.2) 72 82.78 0.87 (0.68–1.1) 118 99.64 1.18 (0.98–1.42)
Lymphoma 148 173.82 0.85 (0.72–1) 62 79.52 0.78# (0.6–1) 86 94.3 0.91 (0.73–1.13)
Non-tumor causes
Diseases of heart 6,161 4,945.61 1.25# (1.21–1.28) 2,547 2,140.78 1.19# (1.14–1.24) 3,614 2,804.84 1.29# (1.25–1.33)
COPD and allied cond 1,185 1,194.07 0.99 (0.94–1.05) 470 543.39 0.86# (0.79–0.95) 715 650.67 1.10# (1.02–1.18)
Cerebrovascular diseases 1,183 1,058.31 1.12# (1.06–1.18) 480 455.48 1.05 (0.96–1.15) 703 602.83 1.17# (1.08–1.26)
Nephritis, nephrotic syndrome and nephrosis 1,166 387.89 3.01# (2.84–3.18) 409 165.73 2.47# (2.23–2.72) 757 222.16 3.41# (3.17–3.66)
Diabetes mellitus 1,137 595.36 1.91# (1.8–2.02) 488 265.59 1.84# (1.68–2.01) 649 329.77 1.97# (1.82–2.13)
Accidents and adverse effects 668 602.41 1.11# (1.03–1.2) 293 282.38 1.04 (0.92–1.16) 375 320.03 1.17# (1.06–1.3)
Alzheimer’s 611 701.64 0.87# (0.8–0.94) 242 300.21 0.81# (0.71–0.91) 369 401.43 0.92 (0.83–1.02)
Pneumonia and influenza 489 429.8 1.14# (1.04–1.24) 197 184.8 1.07 (0.92–1.23) 292 245 1.19# (1.06–1.34)
Hypertension without heart disease 482 223.68 2.15# (1.97–2.36) 192 96.06 2.00# (1.73–2.3) 290 127.62 2.27# (2.02–2.55)
Septicemia 406 285.54 1.42# (1.29–1.57) 164 125.48 1.31# (1.11–1.52) 242 160.05 1.51# (1.33–1.71)
Chronic liver disease and cirrhosis 293 220.44 1.33# (1.18–1.49) 149 110.01 1.35# (1.15–1.59) 144 110.44 1.30# (1.1–1.54)
Suicide and self-inflicted injury 151 153.78 0.98 (0.83–1.15) 83 78.18 1.06 (0.85–1.32) 68 75.61 0.9 (0.7–1.14)

SMR standardized mortality ratio, CI confidence interval, COPD chronic obstructive pulmonary disease

#Statistical significance with P < 0.05